Privi Speciality Chemicals Ltd - 530117 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Privi Speciality Chemicals received a 'no objection' letter from BSE for its scheme of amalgamation. This regulatory approval is a key step for the proposed merger with Privi Fine Sciences and Privi Biotechnologies.
May 06 2026 18:05:00
Privi Speciality Chemicals Limited
Privi Speciality Chemicals Limited received a 'no objection' letter from BSE for its scheme of amalgamation with Privi Fine Sciences Private Limited and Privi Biotechnologies Private Limited. This is a crucial regulatory approval moving the merger forward, though other approvals are still pending.
May 06 2026 17:05:00
Privi Speciality Chemicals Ltd - 530117 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Privi Speciality Chemicals received a 'no objection' letter from NSE for its scheme of amalgamation. This is a key regulatory step towards integrating Privi Fine Sciences Pvt Ltd and Privi Biotechnologies Pvt Ltd into the company.
May 06 2026 12:05:00
Privi Speciality Chemicals Limited
Privi Speciality Chemicals received a 'no objection' observation letter from the National Stock Exchange of India on May 05, 2026, for its proposed scheme of amalgamation. This marks a significant regulatory milestone for the merger plan.
May 06 2026 12:05:00
Privi Speciality Chemicals Ltd - 530117 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Privi Speciality Chemicals will conduct an earnings conference call on May 12, 2026, at 4:00 p.m. IST. The call will cover the company's operational and financial performance for Q4 & FY26.
May 04 2026 15:05:00
Privi Speciality Chemicals Ltd - 530117 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Privi Speciality Chemicals will hold an earnings conference call on May 12, 2026, at 4:00 p.m. IST. The call will cover the company's operational and financial performance for the fourth quarter and full fiscal year 2026, and a transcript will be available within five working days.
May 04 2026 15:05:00
Privi Speciality Chemicals Limited
Privi Speciality Chemicals board will convene on May 11, 2026, to consider and approve its audited financial results for the fiscal year ended March 2026. The board will also discuss and recommend a final dividend for shareholders.
May 02 2026 17:05:00
Privi Speciality Chemicals Ltd - 530117 - Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On May 11,2026.
Privi Speciality Chemicals board will convene on May 11, 2026, to approve its audited Q4 FY26 standalone and cons. financial results. The board will also consider the declaration of a final dividend for shareholders.
May 02 2026 17:05:00
Privi Speciality Chemicals Limited
Privi Speciality Chemicals' long-term credit rating of AA-/Stable and short-term rating of A1+ were reaffirmed by CRISIL. These ratings apply to the company's ₹1118 crore debt instruments and bank facilities.
Apr 21 2026 13:04:00
Privi Speciality Chemicals Limited
Privi Speciality Chemicals' long-term credit rating of AA-/Stable and short-term rating of A1+ were reaffirmed by CRISIL. These ratings apply to the company's ₹1118 crore debt instruments and bank facilities.
Apr 21 2026 13:04:00
Read More